NCT05020652 2025-12-17A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk MyelofibrosisChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2 Active not recruiting107 enrolled